[Efficacy of treatment with donor lymphocytes and interleukin-2 in a patient with two posttransplantation recurrences of acute myeloid leukemia].
Zhelnova Ei, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Shpakova Ap, Kalinin Nn, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Poreshina Lp, Kaplanskaia Ib, Demidova Ia, Liubimova Ls, Kut'ina Rm, Е. Н. Паровичникова(National Research Center for Hematology Russian Academy of Medical Sciences)
PubMed
January 1, 2007
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59